Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Injection for Knee Osteoarthritis and Periarticular Tissue Injury
NCT06082531Recruiting
- Sponsor
- Xijing Hospital
- Start
- Sep 2023
- Primary completion
- Dec 2026
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Trial of platelet-rich plasma in osteoarthritis (OA), meniscus disorder and cartilage injury (3 arms), sponsored by Xijing Hospital. Primary endpoints: X-ray imaging evaluation at 6 months, Computed Tomography evaluation at 6 months and 1 more. Started Sep 2023; status: recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
osteoarthritis (OA)meniscus disordercartilage injury
Beyond the preview
Go deeper on NCT06082531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06082531.